Mitsune Tanimoto - Concepedia

Author

Mitsune Tanimoto

Also Known As

Hideo Tanaka, K Matsuo, Keitaro Matsuo, M Harada, M TANIMOTO, M Tanimoto, M. Tanimoto, M., Tanimoto, MITSUNE TANIMOTO, Miguel Tanimoto

845

Publications

18.7K

Citations

H-Index

238

Concepts

All Affiliations

Okayama University Okayama University Hospital Nagoya University Aichi Cancer Center Kawasaki Medical School

About

Mitsune Tanimoto is an author at Okayama University specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	179	7.1K
2	Health Sciences	20	38	963
3	Education	1	1	16
4	Language Studies	1	1	16
5	Natural Sciences	1	1	34

Mitsune Tanimoto

333

Publications

16.5K

Citations

H-Index

Page 1

	Year	Citations
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial Steven M. Horwitz, Owen A. O’Connor, Barbara Pro, The Lancet	2018	707
Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines Fumihiko Hayakawa, Masayuki Towatari, Hitoshi Kiyoi, Oncogene Signal TransductionSignaling PathwayCell RegulationCell InteractionReceptor Tyrosine Kinase	2000	559
The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung Cancers Masaki Tokumo, Shinichi Toyooka, Katsuyuki Kiura, Clinical Cancer Research	2005	495
Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma Michinori Ogura, Takashi Ishida, Kiyohiko Hatake, Journal of Clinical Oncology	2014	357
All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group [see comments] A Kanamaru, Y Takemoto, Mitsune Tanimoto, Blood	1995	250
Phase III Trial Comparing Docetaxel and Cisplatin Combination Chemotherapy With Mitomycin, Vindesine, and Cisplatin Combination Chemotherapy With Concurrent Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: OLCSG 0007 Yoshihiko Segawa, Katsuyuki Kiura, Nagio Takigawa, Journal of Clinical Oncology	2010	246
Lineage-Specific Dependency of Lung Adenocarcinomas on the Lung Development Regulator TTF-1 Hisaaki Tanaka, Kiyoshi Yanagisawa, Keiko Shinjo, Cancer Research	2007	216
Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas. Takashi Oka, Mamoru Ouchida, Maho Koyama, PubMed Epigenetic ChangeGeneticsMixed-phenotype Acute LeukemiaPathologyFunctional Loss	2002	211
Identification of Epigenetic Aberrant Promoter Methylation in Serum DNA Is Useful for Early Detection of Lung Cancer Keiichi Fujiwara, Nobukazu Fujimoto, Masahiro Tabata, Clinical Cancer Research	2005	202
Emergence of Epidermal Growth Factor Receptor T790M Mutation during Chronic Exposure to Gefitinib in a Non–Small Cell Lung Cancer Cell Line Atsuko Ogino, Hiroyuki Kitao, Seiki Hirano, Cancer Research	2007	195

Page 1